# A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)

> **NCT01533532** · PHASE2 · COMPLETED · sponsor: **Kissei Pharmaceutical Co., Ltd.** · enrollment: 100 (—)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** KLH-2109
- **DRUG:** KLH-2109
- **DRUG:** KLH-2109
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01533532
- **Lead sponsor:** Kissei Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 100 (—)
- **Last updated:** 2014-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01533532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01533532, "A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01533532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*